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SUPPLEMENT 
MATERIALS AND METHODS 
Antibodies and Reagents 
The following commercially available antibodies were used: anti-trimethyl-
Histone H3 (Lys9) (07-523) and anti-dimethyl-Histone H3 (Lys9) (07-441) from Upstate, 
anti Br-tri-metH3K9 antibodies are a gift of Dr. Jenuwein.  
Chromatin Immunoprecipitation Assay 
Pituitary glands were collected at different developmental times (e12.5, e14.5, 
e17.6, adult) and crosslinked using 1% formaldehyde for 1 hour at room temperature, and 
the extracts were sonicated until the DNA fragments were 300–500 bp in size. The 
crosslinked adducts extracts were subsequently incubated with 1-2 !g IgG or antibodies 
overnight at 4 °C and followed by Dynabeads recovery (Dynal) for 2 hr as described in 
(1) After extensive washing of the beads, DNA-proteins complexes were eluted and 
crosslinking was reversed for overnight at 65 °C. After DNA purification with QIAquick 
spin column (Qiagen), PCR was performed at 25-30 cycles.  The .5% input chromatin 
(Input) and no antibodies beads  (Control) were used to control the CHiP results. In the 
absence of pure somatotrope or lactotrope cell populations in adult pituitary, we used the 
presence of RNA polymerase II (Pol II) and the ability of Pit-1 to act as an N-CoR-
dependent repressor as the criterion for separating actively transcribed genes from non-
transcribed genes in the cells of Pit1 lineage. Previously we have evaluated the 
association of Pit-1 and N-CoR with the growth hormone promoter in vivo (for detailed in 
formation see (1). Following formaldehyde cross-linking, DNA chromatin preparations 
from adult mouse pituitary glands were subjected to a two-step ChIP analysis. After a 
first round of IP with anti-Pol II (-Pol II) IgG, the bound (+) and unbound (-) fractions 
were subjected to a second round of ChIP with either -N-CoR or -Pit-1 IgGs. Polymerase 
chain reaction amplification with primers specific for the mouse growth hormone gene 
promoter detected occupancy by Pit-1, but not by N-CoR, in the Pol II (+) fraction. In the 
Pol II (-) fraction, both Pit-1 and N-CoR were associated with the promoter (as shown in 
5). These data suggest that Pit-1 occupies the growth hormone gene promoter in cell 
types that do and do not transcribe the growth hormone gene; however, these data also 
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suggest that N-CoR is selectively recruited only in cells in which the gene is not 
transcribed. We have used the same strategy for cell selection in this manuscript as well.  
Because of usage of Dynabeads allows for the efficient recovery of IP-ed material (see 
www.sciencemag.org/feature/data/1055900.shl in (1) and because of the adult pituitary 
provide the sufficient amount of input material (One adult pituitary equals 2X 10
6
 cells) 
the multy-steps CHIP in adult pituitary are quite feasible. For multi-step ChIP, the 
immunoselective DNA fragments were released from the primary immunoprecipitation 
by pH alteration followed by buffer exchange on the Microcon membrane YM-10 
(Amicon, Inc) as described in www.sciencemag.org/feature/data/1055900.shl in (1) and  
reimmunoprecipitated with the additional antibodies, and processed as described above. 
The primers used to amplify the mouse GH locus are listed below.  
Quantitative ChIP analysis. 
For quantitative ChIP, analysis, immunoprecipitated DNA was used as template 
for PCR amplification with three consecutive primer pairs, which provide products of 
different size with 0.5 µM of each primer. The strategy for PCR amplification is 
represented in the (Supplement Fig. 1B). Samples were loaded on 2% agarose gel 
stained with ethidium bromide. All PCR reactions were performed in triplicate and 
included negative controls (IgG), as well as positive controls (genomic DNA). After 
densitometry results from 3 consecutive repeats (see the groups encircled in Supplement 
Fig. 1B) were averaged and fold of enrichment was normalized against neighboring 
primer segments and averaged intensity of input genomic DNA for any given primer pair 
(Supplement Fig. 1D,E).  
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Table 1. GH locus Tiling 
Primer pairs Forward Reverse Size 
1 AAGAGAAGGAGGCCGATGTT CCTTCTCCCCATCCATTTTA 350 
2 CCAACCCCTTCATACCAACA GCTCTACAGGGCTTGACACC 148 
3 GAACAAATGGGTGGAGAAGG GCTCAGGGGTCTCTGGATTC 250 
4 TGTATGGCGAGGAGTCACAG CTGACTCCAGGCTGTTGGAT 340 
5 CTGAGCATTCAGGGGTTCAT TCAGAGGGGGTTAGGCTACA 157 
6 ATGACCCACCGGTTGAGAAC TTTGTTGGCATACTTTTGCAC 240 
7 CCCTTGTACCAAGCTCAACC CTCCTTGGGCTCAGAGACAG 344 
8 GGGTTGGATCCTCTTTCTCC GGGTGTGGTTCCGTAAGCTA 154 
9 GCCCAGCTAGGTTTTCACTG GAGACCACATTTCAGCAGCA 242 
10 CCGGTTAAACGTTGGTGTTT GCACAGAATGGTTCCTCCTC 346 
11 GTGGGAGGAATCAAGGGAAT ATGAGGCACACTGAAACGTG 140 
12 CTCTCCAAGAAGGCGATGTC AGGAGGAAGAAGGGGACAGA 251 
13 GGAAAGAAGGGCAGGAGACT CCTCAGGACATGGAATTGCT 358 
Legend:  Primers used for GH locus tiling. 
FISH analysis and immunostaining. 
FISH analysis was performed with 320 bp  sequence to GH promoter (1) as described in 
(2).  
Enhancer-Blocking Assay 
The CMVEmPlucp(A) plasmid (5.5 kb, a generous gift from Satoshi Watanabe, 
here called pELuc) (Supplement Fig. 2C), carrying a Firefly luciferase reporter gene 
cassette with the late polyadenylation site from SV40, under the control of the CMV 
minimal promoter and enhancer, with suitable cloning sites located 5’ (distal from the 
CMV promoter, PstI or SmaI) and 3’ (proximal to the CMV promoter, XhoI) at either end 
of the enhancer piece, was used as a backbone for the subsequent construction of 
experimental and control plasmids described in this manuscript. The CMVmPlucp(A) 
plasmid (4.9 kb, a generous gift from Satoshi Watanabe, here called pLuc), derived from 
pELuc and lacking the CMV enhancer was also used as a reference.  
Six fragments from the mouse growth hormone region -10 -14 , called B, C, D, E, 
F and G, were obtained by PCR and cloned into pELuc in different combinations (BC: B 
to C, 1.1 kb; BD: B to D, 2 kb; CD: C to D, 1.1 kb; CE: C to E, 2.55 k; FG: F to G, 1.35 
kb), both proximal (at the XhoI site) and distal (at the PstI site) in relation to the CMV 
promoter, resulting in pEBCLuc/pBCELuc (6.6 kb), pEBDLuc/pBDELuc (7.5 kb), 
pECDLuc/pCDELuc (6.6 kb), pECELuc/pCEELuc (8.05 kb), and pEFGLuc/pFGELuc 
(6.85 kb) experimental plasmids, respectively. A number of controls were prepared and 
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used for the enhancer-blocking assay in transiently transfected cells. First, the 5’HS4 
insulator element, from the chicken b-globin locus (1.2 kb,(19,23 24); from pBC1 
plasmid, Invitrogen) was cloned into pELuc, at Pst I and Xho I sites, resulting in 
pE5’HS4Luc/p5’HS4ELuc (6.7 kb) plasmids. Second, the wild-type FII/FIII (here called 
F8 fragment) and mutant FII/FIIIDctt (carrying a mutated CTCF-binding site, here called 
F6 fragment) core elements from the 5’HS4 insulator element (0.1 kb, (3), a generous 
gift from Félix Recillas-Targa) were cloned into pELuc, at Pst I (or Sma I, for F6) and 
Xho I sites, resulting in pEF8Luc/pF8ELuc (5.6 kb) and pEF6Luc/pF6ELuc plasmids, 
respectively. 
Plasmid DNAs were purified using Qiagen Plasmid Maxi Kit (Qiagen). All 
plasmids were confirmed by restriction enzyme and sequence analyses. Detailed 
description of plasmids is available upon request.  
 Human embryonic kidney 293 (HEK 293) cells or HeLa cells were grown in 
Dulbecco's Modified Eagle Medium (DMEM), supplemented with 10% (v/v) fetal calf 
serum, 2 mM glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and 10 mM 
HEPES pH=7.4, and 1x non-essential amino acids (Sigma) and were incubated at +37
o
C, 
5% CO2 and 98% humidity. All cell-culture reagents, except those indicated, were 
purchased from Invitrogen. 
Transient transfection enhancer-blocking assays (EBA) were carried out, in 
triplicates, using Lipofectamine 2000 (Invitrogen), according to the supplier. In brief, the 
day before transfection ~1.8x10
5
 cells were seeded (in normal medium with serum and 
additives without antibiotics) in each of 24-well plates, so that they were 90-95% 
confluent on the day of transfection. On the day of transfection, a mixture of 
Lipofectamine 2000/DNA was prepared and added, in OPTI-MEM! medium 
(Invitrogen), to cells. For each well, 0.66 mg of experimental plasmid and 0.14 mg of 
pCMV-Luc control plasmid (for normalisation purposes) were cotransfected. All 
experimental and control plasmids were linearized before transfection (to avoid 
bidirectional enhancer activity, as discussed in (4) using a Kpn I site located 3’ 
downstream from the polyadenylation signal in all pELuc-derived constructs (with the 
exception of pEF8Luc/pF8ELuc plasmids, which were linearized using Apa I, due to an 
internal Kpn I site within the F8 fragment). pCMV-luc control plasmid was linearized 
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using Sca I. Successful quantitative linearization was verified in a standard horizontal 
agarose (1% w/v) electrophoresis gel. 
 Transfected cells were harvested 24 hours after transfection. Whole-cell protein 
extracts were prepared in Reporter Lysis Buffer (Promega) and luciferase assays were 
performed using Luciferase Assay Reagent (Promega), as recommended by supplier. The 
chemiluminescence associated with luciferase activity was measured in a microplate 
luminometer (Orion, Berthold Detection Systems). Normalization of the luciferase 
reporter values between different transfected constructs was achieved taking into account 
the activity of the co-transfected pCMV-Luc reporter plasmid and the number of 
molecules (picomols) of experimental plasmid DNA (according to each plasmid size) 
used in each transfection. Relative transactivations were expressed as mean values from 
triplicate experiments (+/- SD). Transfection experiments were repeated three times, 
independently, with comparable results. 
RT-PCR Analysis 
 Pituitary glands dissected at different developmental stages were rinsed in PBS, 
harvested, and lysed in the presence of a highly denaturing buffer (RNeasy Kit, Qiagen). 
The lysate were collected and pipetted directly onto a QIAshredder spin column to shear 
the genomic DNA. Ethanol was added to adjust the binding conditions, and the sample 
was applied to an RNeasy spin column for binding of total RNA, following the 
manufacturer protocol (Qiagen). First strand cDNA synthesis from total RNA template 
and PCR amplification of the resulting cDNA were combined in a single tube reaction, 
using an uninterrupted thermal-cycling program (ProSTAR HF Single-Tube RT-PCR 
System, Stratagene). Reactions were carried out using 50 ng of total RNA. 
SINE B2 Expression For detection of SINE B2 expression in vivo we have used 
strand-specific extension  to generate single-stranded DNA . Primers “Y” and “2” were 
used as an reverse transcriptase primers for obtaining specific sDNA from the RNA 
originated form Pol II transcribed strand. Composition of primer pairs  “1” and “Y”, or 
“Y” and “2” were used for subsequent PCR reaction as shown in Figure 2D.  For 
detection of POl III transcript primers “ 3” and “4” were used in RT reaction, and primer 
pairs “2-3” and “2-4” for subsequent PCR (Fig. 2D and 2C). We have shown 
representative relevant for this method controls in Figure 3C. To show that our RNA 
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samples do not have contamination with DNA we have used growth hormone promoter 
specific primer set (GH-pr, Fig. 3C, Supplement Fig. 4A) for reverse transcriptase 
reaction and subsequent PCR analysis. Panel A of supplementary Fig. 3 shows that all the 
chosen primer pairs work efficiently when the genomic DNA used as a template. The 
absence of band in GH-pr line for RNA samples from different stages of pituitary 
development indicates the absence of DNA contaminants and therefore proof validity of 
the RT-PCR. We have used the same sampled material for detection of the Pol II and Pol 
III transcripts generated from the SINE B2 locus, therefore we did not include the repeat 
of the control panels in each gel presented in Figure 3.   The primers used for detection 
of SINE B2 transcripts are listed below; 
Table 2. Transcript Specific Reverse Transcriptase Primers 
Name Sequence 
Y AAAATGAAGTCTAGGCCCTCA 
2 ACACAGCCCTCTTCTTCTTGT 
3   GGAGCCCACAGCAAACTCT 
4 CTGTCAAGGTAGGGCCAAAG 
5 TCAGAGGGGGTTAGGCTACA 
 
T-PCR  Primers 
Name Sequence 
Y   AAAATGAAGTCTAGGCCCTCA 
1   CACCAGAAGAGGGCGTCAGAT 
2   ACACAGCCCTCTTCTTCTTGT 
3   GGAGCCCACAGCAAACTCT 
4   CTGTCAAGGTAGGGCCAAAG 
5   TCAGAGGGGGTTAGGCTACA 
        6,7   
  ACCACACCTTCCAACTCTGC 
  CAGTCCCCAGGAAAGACAGA  
"-actin 
  GCTCCGGCATGTGCAA 
  AGGATCTTCATGAGGTAGT 
 Legend:  Transcript-specific. 
Analysis of mGH/RFP — BAC Transgenic Mice 
 The RPCI23-418011 BAC clone was obtained from Children’s Hospital of 
Oakland Research Institute (CHORI) and contains 220KB pairs of mouse sequence 
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containing the GH gene centered near the middle of the BAC.  To study gene expression 
of the GH, the GH gene was substituted with a natural RFP dimer (graciously provided 
by R. Tsien) (5) using the none replicating pLD53.SCAEB shuttle vector system as 
described by Gong S. (2) .  . Sequences containing the left and right arms flanking –320 of the 
rat promoter and the natural red dimer coding sequence which in effect substitutes the 
mouse promoter and the entire GH ORF were cloned into the AscI and PacI sites of 
pLD53.SCAEB. The recombination was accomplished with arms consisting of 500 bp 
unique up- and down-stream homologous mouse sequence.  Recombined clones were 
selected using ampicillin and the removal of the pLD53.SCAEB vector sequence in a 
second recombination event was counter selected with 5% sucrose (against SacB gene).  
Positive clones were identified by PCR and Southern analysis and the area of substitution 
was confirmed by direct sequencing from the BAC.  The integrity of the BAC cloned was 
verified using DNA fingerprint analysis with BamHI and comparing pattern with the 
original BAC clone. The deletion of the SINE B2 element was carried out using a 2-step 
recombination event with selection based on the presence then absence of the galactose 
kinase gene (GalK) Briefly, 50 bp arms flanking the deleted region were used to PCR 
amplify the GalK selection gene. The PCR product was electroporated into the SW102 
line containing the BAC.  The recombination event was selected using minimal plates 
containing galactose as the sole sugar source.  The recombination event incorporated the 
GalK gene into the targeted locus and then a second recombination event with synthetic 
oligos with the same arms but lacking the GalK gene was electroporated into the galK 
containing BAC SW102 line.  The recombination event was selected on minimal plates 
containing 2-deoxy-galactose (DOG).  The recombination events were verified by PCR 
and the integrity of the BAC by DNA fingerprinting.  The deletion was confirmed by 
direct sequencing of the PCR products using primers distal from the deleted area.  
 The BAC transgenes were purified and sent to the UCSD transgenic core facility 
for pronuclear microinjection into embryos and genotyped as described elsewhere. 
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SUPPLEMENTARY FIGURES 
Figure S1. A. Expression of GH transcripts by in situ hybridization during pituitary 
development. B. In the experiment depicted in the Fig. 1C positioning of the GH gene in 
DAPI–dense area (e12.5) can be observed in all the “readable nuclei” 90% (65) of the 
total population of the cells on the slide (72).10% of the cells on the slide include broken 
nuclei and cells with no penetration of the FISH probe. Repositioning of the GH gene to 
euchromatic compartments can be recorded in 94%(102) nuclei out of total (109 nuclei) 
population of the cells on the slide at e14.5 (6% accounts for the broken /non-readable), 
and in 90% (70) out 77 total nuclei on the slide at e17.5 (10% broken nuclear/non-
readable) C. Schematic diagram of primer pairs utilized, in groups of three, for 
conventional ChIP analysis using anti- Br-tri-Me H3-K9.  Matched primers were chosen 
to give different sized PCR products permitting simultaneous visualization and providing 
controls. D. An example of the primary data of e12.5 and e14.5 pituitary analysis across 
the GH locus. E.  Input chromatin was used as a control for the primer pair efficiency and 
for the normalization purpose. 
 
Figure S2. A. Sequence of the murine putative insulator CD in the GH locus. The red 
highlight is the SINE B2 repeat. B. Representation of the results of the enhancer–
blocking assay in relative fold of construct expression. C. Schematic representation of the 
plasmid pECLuc ( CMVEm Pluc) used in enhancer-blocking assay.  
 
Figure S3. The SINE B2 repeat on the mGH locus is functionally important for 
transcriptional activity of GH. A. The RPC123-418001 mGH BAC (220 kb) was 
modified to predict the GH coding requirement a RFP dimer using the pLD53.SCAEB 
shuttle vector system. Deletion of the SINE B2 element was achieved using two-step 
recombination strategy. B. qPCR proof of BAC founder transgenic mice of WT and 
ΔSINE B2 constructs.  
 
Figure S4. Determinants of enhancer blocking function of the GH SINE B2 
transcription unit. A.  Assessing the role of the SINE B2 transcript in trans. The CD 
element encompassing the GH SINE B2 transcription unit was inserted in the enhancer-
blocking construct, both upstream and downstream of the enhancer.  Upstream of the 
enhancer (PstI) the wild-type CD element was inserted, but downstream of the enhancer 
(XhoI), the insert was either the wild-type CD element or a CD element that contained                              
transcription unit, in the CD element. Expression of SINE B2 upstream failed to cause 
enhancer binding by the mutant downstream GH SINE B2 element. All data is ± SEM. 
 




